1Raza A,Gezer S,Mundle S,et al. Apoptosis in bone marrow biopsy samples involving stromal and hemapoitic cells in 50 patients with myelodysplatic syndromes[J]. Blood,1995,86:268.
2Verhoef GEG,de Scouwer P,Ceuppens JL,et al. Measurement of serum cytokine levels in patients with myelodysplastic syndromes[J]. Leukemia,1992,6:1268.
3Kitagawa M,Saito I,kuwata T,et al. Overexpression of tumor necrosis factor (TNF)-alpha and interferon (TNF)-gamma by bone marrow cells from patients with myelodysplastic syndromes[J]. Leukemia,1997,11:2049.
4Davis RE, Greenberg PL. Bcl-2 expression by myeloid precursons in myelodysplastic syndromes:relation to disease progression[J]. Leuk Res, 1998,22:767.
6Feng J,Funk WD,Wang SS,et al. The DNA component of human telomerase[J]. Science,1995,269:1236.
7Boultwood J,Fidler C,Kusec R,et al. Telomere length in myelodysplastic syndromes[J]. Am J Hematol,1997,56:266.
8Ohyashiki JH,Iwama H,Yahata N,et al. Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes[J]. Clin Cancer Res,1999,5:1155.
